288. 自己免疫性後天性凝固因子欠乏症 Autoimmune acquired coagulation factor deficiency Clinical trials / Disease details

臨床試験数 : 206 /  薬物数 : 231 - (DrugBank : 28) / 標的遺伝子数 : 10 - 標的パスウェイ数 : 21

  
3 trials found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1EUCTR2004-005051-34-BE
(EUCTR)		18/04/200531/05/2007Efficacy and safety study of vWF SD-35-DH (WILFACTIN) in children under 6 years of age - NOT APPLICABLEEfficacy and safety study of vWF SD-35-DH (WILFACTIN) in children under 6 years of age - NOT APPLICABLE Von Willebrand disease
Classification code 10047715		Trade Name: WILFACTIN
Product Name: WILFACTIN
Product Code: VWF SD-35-DH
INN or Proposed INN: human von Willebrand factor		LFB BIOTECHNOLOGIESNULLNot RecruitingFemale: yes
Male: yes		15Belgium
2EUCTR2005-001746-17-BE
(EUCTR)		13/04/200512/11/2007EFFICACY AND SAFETY STUDY OF vWF SD-35-DH (WILFACTIN) IN PATIENTS UNDER LONG TERM PROPHYLAXISEFFICACY AND SAFETY STUDY OF vWF SD-35-DH (WILFACTIN) IN PATIENTS UNDER LONG TERM PROPHYLAXIS von Willebrand disease
Classification code 10047715		Trade Name: WILFACTIN
Product Name: WILFACTIN
Product Code: VWF SD-35-DH
INN or Proposed INN: Human von Willebrand Factor		LFB BIOTECHNOLOGIESNULLNot RecruitingFemale: yes
Male: yes		6Phase 4Belgium
3EUCTR2005-001746-17-PL
(EUCTR)		20/01/2009EFFICACY AND SAFETY STUDY OF vWF SD-35-DH (WILFACTIN) IN PATIENTS UNDER LONG TERM PROPHYLAXISEFFICACY AND SAFETY STUDY OF vWF SD-35-DH (WILFACTIN) IN PATIENTS UNDER LONG TERM PROPHYLAXIS von Willebrand disease
MedDRA version: 9.1;Level: LLT;Classification code 10047715;Term: Von Willebrand's disease		Trade Name: WILFACTIN
Product Name: WILFACTIN
Product Code: VWF SD-35-DH
INN or Proposed INN: Human von Willebrand Factor		LFB BIOTECHNOLOGIESNULLNot RecruitingFemale: yes
Male: yes		15Phase 4Belgium;Poland